<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Week 1 HW: Final Project Ideas :: farrel-alfaza-marsetyo</title><link>https://pages.htgaa.org/2026b/farrel-alfaza-marsetyo/week-01-hw-project-ideas/index.html</link><description>(1) What you would like to biomanufacture and why?&#10;I want to make a modular production system for rare disease drugs. Rare disease, and their drugs known as orphan drugs are heavily financially disincentivized for big pharma since it’s not profitable. Why is it not profitable? High research price, specialized equipment needed to make it (big pharma are geared to make high demand drugs, and their production infrastructure reflects it), and low demand. Research price will possibly be reduced faster by AI use in biomedical research, but what about production costs? I believe that a modular production system based on living systems and synthetic biology principles could solve this problem. Lowering cost and making orphan drugs more accessible. Who is it for? Fundamentally it is for the patients and their loved ones, while this system could also be marketed to pharma companies to increase their outreach and scalability. I think mainly however this would be an open source platform so that more people could access it. Orphan drugs are very diverse however, and not all orphan drug types are feasible to be produced this way, at least meaningfully. Although theoretically I want this platform to be able to produce all orphan drugs in the world, however, early proof-of-concept prototypes must focus on an orphan drug(s) with these criterias:</description><generator>Hugo</generator><language>en</language><atom:link href="https://pages.htgaa.org/2026b/farrel-alfaza-marsetyo/week-01-hw-project-ideas/index.xml" rel="self" type="application/rss+xml"/></channel></rss>